Recent advances in the management of infections in cancer patients.
Boyer
M J
MJ
Department of Medicine, Princess Margaret Hospital, Toronto, Ontario, Canada.
McGeer
A
A
Feld
R
R
D000380:Agranulocytosis / Q000150:complications / Q000628:therapy; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000627:therapeutic use; D017053:Infection Control; D007239:Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D015337:Multicenter Studies as Topic; D009369:Neoplasms / Q000150:complications*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D000890:Anti-Infective Agents; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors